bioAffinity Technologies News

4: Statement of changes in beneficial ownership of securities-Officer Zannes Maria

Apr 25 04:05

4: Statement of changes in beneficial ownership of securities-Officer Zannes Timothy P

Apr 25 04:05

4: Statement of changes in beneficial ownership of securities-Director GIRGENTI STEVEN

Apr 25 04:05

424B3: Prospectus

Apr 18 01:06

EFFECT: Others

Apr 17 18:09

bioAffinity Technologies | ARS: Annual Report to Security Holders

Apr 15 18:38

bioAffinity Technologies | DEF 14A: Definitive information statements

Apr 15 18:33

bioAffinity Technologies | DEFA14A: Others

Apr 15 18:29

bioAffinity Technologies | EFFECT: Others

Apr 8 18:07

bioAffinity Technologies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 5 18:12

bioAffinity Technologies | S-1: General form for registration of securities under the Securities Act of 1933

Apr 5 05:11

bioAffinity Technologies | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 3 05:27

bioAffinity Technologies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 3 01:12

bioAffinity Technologies | 10-K: Annual report

Apr 2 04:08

bioAffinity Technologies | 8-K: bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 2 04:04

bioAffinity Technologies | 4: Statement of changes in beneficial ownership of securities-Officer GIRGENTI STEVEN

Mar 30 04:58

bioAffinity Technologies | 4: Statement of changes in beneficial ownership of securities-Director Anderson Robert A.

Mar 30 04:53

bioAffinity Technologies | D: Filing D

Mar 21 02:28

bioAffinity Technologies | 8-K: Securities Purchase Agreement

Mar 14 04:10

bioAffinity Technologies | 8-K: bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Mar 9 06:02